Filed: 2/14/2023ACC: 0000950123-23-002335
📋 What this filing means
ABG INNOVATION CAPITAL PARTNERS III GP LTD filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $1.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$1.31M
Total AUM (reported)
322.45K
Total Shares
Allocation by class
COM$1.29M98.5%
COM PAR$19.7K1.5%
Portfolio Concentration
Top 3$1.29M98.5%
4–10$19.7K1.5%
Top 3 weight
98.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 322.45K
Sole
Full voting authority
322.45K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other4
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
CASTLE BIOSCIENCES INC
DFNDShares33.63K
TypeSH
Market value$791.6K
60.43%
Sole
33.63K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
DFNDShares26.67K
TypeSH
Market value$342.1K
26.12%
Sole
26.67K
Shared
0.00
None
0.00
SYNLOGIC INC
DFNDShares205.91K
TypeSH
Market value$156.5K
11.95%
Sole
205.91K
Shared
0.00
None
0.00
IDERA PHARMACEUTICALS INC
DFNDShares56.25K
TypeSH
Market value$19.7K
1.50%
Sole
56.25K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CASTLE BIOSCIENCES INCDFND | COM | 33.63K | SH | $791.6K 60.43% | 33.63K | 0.00 | 0.00 |
AADI BIOSCIENCES INCDFND | COM | 26.67K | SH | $342.1K 26.12% | 26.67K | 0.00 | 0.00 |
SYNLOGIC INCDFND | COM | 205.91K | SH | $156.5K 11.95% | 205.91K | 0.00 | 0.00 |
IDERA PHARMACEUTICALS INCDFND | COM PAR | 56.25K | SH | $19.7K 1.50% | 56.25K | 0.00 | 0.00 |